Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 4 (2007), Issue 5 (May)

1. Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer.
   Prostate, 67(9): 976-88. [Abstract] [Full-text]
2. Can bipolar disorder-specific neuropsychological impairments in children be identified?
   J Consult Clin Psychol, 75(2): 210-20. [Abstract] [Full-text]
3. Application of the Cockcroft-Gault method to estimate lithium dosage requirement.
   Psychiatry Clin Neurosci, 61(3): 269-74. [Abstract] [Full-text]
4. Clinical importance of caffeine dependence and abuse.
   Psychiatry Clin Neurosci, 61(3): 263-8. [Abstract] [Full-text]
5. Japanese midwives as psychiatric diagnosticians: application of criteria of DSM-IV mood and anxiety disorders to case vignettes.
   Psychiatry Clin Neurosci, 61(3): 226-33. [Abstract] [Full-text]
6. Aripiprazole: pharmacology and evidence in bipolar disorder.
   Expert Opin Pharmacother, 8(7): 1001-9. [Abstract] [Full-text]
7. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania.
   Prog Neuropsychopharmacol Biol Psychiatry, 31(4): 887-91. [Abstract] [Full-text]
8. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder.
   Prog Neuropsychopharmacol Biol Psychiatry, 31(4): 952-5. [Abstract] [Full-text]
9. Mania in a case of hyperparathyroidism.
   Psychosomatics, 48(3): 265-8. [Abstract] [Full-text]
10. MLC1 polymorphisms are specifically associated with periodic catatonia, a subgroup of chronic schizophrenia.
    Biol Psychiatry, 61(10): 1211-4. [Abstract] [Full-text]
11. Dysbindin gene variants are associated with bipolar I disorder in a Korean population.
    Neurosci Lett, 418(3): 272-5. [Abstract] [Full-text]
12. Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress.
    Arch Gen Psychiatry, 64(5): 555-64. [Abstract] [Full-text]
13. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.
    Arch Gen Psychiatry, 64(5): 543-52. [Abstract] [Full-text]
14. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia.
    Arch Gen Psychiatry, 64(5): 521-9. [Abstract] [Full-text]
15. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.
    Proc Natl Acad Sci U S A, 104(19): 8131-6. [Abstract] [Full-text]
16. Veterans Affairs Health System and mental health treatment retention among patients with serious mental illness: evaluating accessibility and availability barriers.
    Health Serv Res, 42(3): 1042-60. [Abstract] [Full-text]
17. Three clinical cases of DSM-IV mania symptoms in preschoolers.
    J Child Adolesc Psychopharmacol, 17(2): 237-43. [Abstract] [Full-text]
18. Proposed definitions of bipolar I disorder episodes and daily rapid cycling phenomena in preschoolers, school-aged children, adolescents, and adults.
    J Child Adolesc Psychopharmacol, 17(2): 217-22. [Abstract] [Full-text]
19. Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine.
    J Psychiatr Res, 41(10): 821-7. [Abstract] [Full-text]
20. An epidemiological investigation of affective disorders with a population-based cohort of 1023 adults with intellectual disabilities.
    Psychol Med, 37(6): 873-82. [Abstract] [Full-text]
21. The long-term course of depressive disorders in the Lundby Study.
    Psychol Med, 37(6): 883-91. [Abstract] [Full-text]
22. Suicide and other causes of mortality in bipolar disorder: a longitudinal study.
    Psychol Med, 37(6): 839-47. [Abstract] [Full-text]
23. Diagnostic stability and evolution of bipolar disorder in clinical practice: a prospective cohort study.
    Acta Psychiatr Scand, 115(6): 473-80. [Abstract] [Full-text]
24. Carnitine as an antidote for acute valproate toxicity in children.
    Curr Opin Pediatr, 19(2): 206-10. [Abstract] [Full-text]
25. Quetiapine for acute mania in bipolar disorder.
    Am J Health Syst Pharm, 64(10): 1045-53. [Abstract] [Full-text]
26. God's will, God's punishment, or God's limitations? Religious coping strategies reported by young adults living with serious mental illness.
    J Clin Psychol, 63(6): 529-40. [Abstract] [Full-text]
27. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
    J Psychiatr Res, 41(10): 828-36. [Abstract] [Full-text]
28. Hippocampal CA1 Pyramidal Cell Size is Reduced in Bipolar Disorder.
    Cell Mol Neurobiol, 27(3): 351-8. [Abstract] [Full-text]
29. Neuropsychiatric syndromes associated with multiple sclerosis.
    J Neurol, 254: II73-II76. [Abstract] [Full-text]
30. The armamentarium of treatments for bipolar disorder: a review of the literature.
    Int J Neuropsychopharmacol, 10(3): 411-31. [Abstract] [Full-text]
31. Comparison of diagnostic guidelines for juvenile bipolar disorder.
    Aust N Z J Psychiatry, 41(6): 479-84. [Abstract] [Full-text]
32. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome.
    Schizophr Bull, 33(3): 703-14. [Abstract] [Full-text]
33. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials.
    J Am Acad Child Adolesc Psychiatry, 46(6): 687-700. [Abstract] [Full-text]
34. Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients.
    Psychoneuroendocrinology, 32(5): 464-9. [Abstract] [Full-text]
35. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
    Med Care, 45(6): 545-52. [Abstract] [Full-text]
36. Clozapine-resistant psychosis, smoking, and caffeine: managing the neglected effects of substances that our patients consume every day.
    Am J Ther, 14(3): 314-8. [Abstract] [Full-text]
37. Lithium increases PGC-1alpha expression and mitochondrial biogenesis in primary bovine aortic endothelial cells.
    FEBS J, 274(11): 2749-65. [Abstract] [Full-text]
38. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
    Int Clin Psychopharmacol, 22(4): 221-5. [Abstract] [Full-text]
39. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Int Clin Psychopharmacol, 22(4): 212-20. [Abstract] [Full-text]
40. The role of comorbid psychiatric conditions in health status in epilepsy.
    Epilepsy Behav, 10(4): 539-46. [Abstract] [Full-text]
41. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.
    Neurosci Lett, 420(1): 45-48. [Abstract] [Full-text]
42. Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system.
    Eur J Pharmacol, 565(1): 119-24. [Abstract] [Full-text]
43. The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics.
    Neurosci Biobehav Rev. [Abstract] [Full-text]
44. Identification of two risk haplotypes for schizophrenia and bipolar disorder in the synaptic vesicle monoamine transporter gene (SVMT).
    Am J Med Genet B Neuropsychiatr Genet, 144(4): 502-7. [Abstract] [Full-text]
45. Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness.
    Psychiatr Serv, 58(6): 864-7. [Abstract] [Full-text]
46. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder.
    Psychiatr Serv, 58(6): 855-63. [Abstract] [Full-text]
47. What lies between hypomania and bipolar disorder? A qualitative analysis of 12 non-treatment-seeking people with a history of hypomanic experiences and no history of major depression.
    Psychol Psychother. [Abstract] [Full-text]
48. Nursing processes used in the treatment of patients with bipolar disorder.
    Int J Ment Health Nurs, 16(3): 168-77. [Abstract] [Full-text]
49. Atypical antipsychotics as "mood stabilizers": a retrospective chart review.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(5): 1064-7. [Abstract] [Full-text]
50. Hyperinsulinaemia associated with beta-adrenoceptor antagonist in medicated bipolar patients during manic episode.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(5): 1038-43. [Abstract] [Full-text]
51. Bipolar disorder: how far are we from a rigorous definition and effective management?
    Prog Neuropsychopharmacol Biol Psychiatry, 31(5): 975-96. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.